Skip to content

Exposure Therapy for Veterans With PTSD and Panic Attacks (Phase 1)

Exposure Therapy for Veterans With PTSD and Panic Attacks (Phase 1)

Status
Completed
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01551199
Enrollment
7
Registered
2012-03-12
Start date
2012-03-31
Completion date
2013-06-30
Last updated
2017-02-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Panic Attacks, PTSD

Brief summary

To evaluate the feasibility, acceptability and effectiveness of Multiple Channel Exposure Therapy-Veterans (MCET-V) as a treatment for returning service members with comorbid posttraumatic stress disorder (PTSD) and panic disorder (PD) in two phases. The first phase of the study will examine the feasibility and acceptability of MCET-V.

Detailed description

With the increasing number of Operations Iraqi Freedom and Enduring Freedom (OIF/OEF) veterans returning from war-zone areas, many will experience anxiety disorders such as PTSD and comorbid problems. Currently, about one in every six OIF/OEF veterans experiences PTSD and co-occurring PD. Although effective treatments exist for treating one or the other, we do not yet have treatments that can simultaneously target PTSD and PD. Thus, recent attention has focused on the development of multi-component treatments that simultaneously address PTSD and PD. This study is the first systematic investigation of a time-limited, multi-component cognitive-behavioral treatment for veterans with specific comorbid anxiety problems. The purpose of the first phase of the study is to evaluate the feasibility and acceptability of the multi-component cognitive-behavioral treatment in an open trial.

Interventions

BEHAVIORALMultiple Channel Exposure Therapy- Veterans

Individual therapy design completed over a 12-week period. The treatment will include psychoeducation about panic attacks and trauma and behavioral and cognitive exposure exercises.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 64 Years
Healthy volunteers
No

Inclusion criteria

* being a veteran of any era; * being enrolled in the Trauma Recovery Program (TRP) at the Michael E. DeBakey Veterans Affairs Medical Center (MEDVAMC), with a current diagnosis of PTSD and PD; * being stable on psychotropic medication for 4 weeks before study participation; and * being at least 18 years of age.

Exclusion criteria

* active substance dependence, or bipolar or psychotic disorders; * severe depression and active suicidal ideation and intent (based on Structured Clinical Interview for DSM-IV disorders \[SCID-IV\] & Beck Depression Inventory-2nd edition \[BDI-II\]); * cognitive impairment as indicated by the St. Louis University Mental Status exam (SLUMS); and * veterans currently receiving psychosocial treatment specifically targeting PTSD or panic symptoms.

Design outcomes

Primary

MeasureTime frameDescription
Clinician Administered PTSD Scale (CAPS)1-week post-treatment (approximately week 14)The CAPS is a clinician-administered interview assessing 17 symptoms of PTSD (based on DSM-IV criteria). Frequency of symptoms are rated on a scale from 0 (never/none) to 4 (daily/almost every day). Intensity of symptoms are rated using a scale of 0 (none) to 4 (extreme). Total severity score is derived by summing the frequency and intensity scores. A recommended cut-off of 45 is used to determine the presence of full PTSD. Higher scores suggest greater symptom severity.

Secondary

MeasureTime frameDescription
Anxiety Disorders Interview Schedule- DSM-IV (ADIS-IV)3 MonthsThe ADIS-IV is a semi-structured diagnostic interview for anxiety disorders (based on DSM-IV criteria). DSM-IV criteria for panic disorder include recurrent unexpected panic attacks and (1) persistant concern or worry about additional panic attacks or their consequences or (2) significant change in behavior related to panic attacks.

Countries

United States

Participant flow

Participants by arm

ArmCount
Multiple Channel Exposure Therapy (MCET)
MCET-V is a cognitive-behavioral treatment for persons with comorbid PTSD and panic attacks Multiple Channel Exposure Therapy- Veterans: Individual therapy design completed twice a week over a 6-week period. The treatment will include psychoeducation about panic attacks and trauma and behavioral and cognitive exposure exercises.
7
Total7

Baseline characteristics

CharacteristicMultiple Channel Exposure Therapy (MCET)
Age, Continuous37 years
STANDARD_DEVIATION 6.9
Beck Anxiety Inventory40.6 units on a scale
STANDARD_DEVIATION 9.93
Beck Depression Inventory36.4 units on a scale
STANDARD_DEVIATION 8.11
Gender
Female
4 Participants
Gender
Male
3 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
— / —
other
Total, other adverse events
0 / 7
serious
Total, serious adverse events
0 / 7

Outcome results

Primary

Clinician Administered PTSD Scale (CAPS)

The CAPS is a clinician-administered interview assessing 17 symptoms of PTSD (based on DSM-IV criteria). Frequency of symptoms are rated on a scale from 0 (never/none) to 4 (daily/almost every day). Intensity of symptoms are rated using a scale of 0 (none) to 4 (extreme). Total severity score is derived by summing the frequency and intensity scores. A recommended cut-off of 45 is used to determine the presence of full PTSD. Higher scores suggest greater symptom severity.

Time frame: 1-week post-treatment (approximately week 14)

ArmMeasureValue (MEAN)Dispersion
MCET-VClinician Administered PTSD Scale (CAPS)29.5 units on a scaleStandard Deviation 23.3
Primary

Clinician Administered PTSD Scale (CAPS)

The CAPS is a clinician-administered interview assessing 17 symptoms of PTSD (based on DSM-IV criteria). Frequency of symptoms are rated on a scale from 0 (never/none) to 4 (daily/almost every day). Intensity of symptoms are rated using a scale of 0 (none) to 4 (extreme). Total severity score is derived by summing the frequency and intensity scores. A recommended cut-off of 45 is used to determine the presence of full PTSD. Higher scores suggest greater symptom severity.

Time frame: 3-month follow-up (approximately week 26)

ArmMeasureValue (MEAN)Dispersion
MCET-VClinician Administered PTSD Scale (CAPS)17 units on a scaleStandard Deviation 1.41
Secondary

Anxiety Disorders Interview Schedule- DSM-IV (ADIS-IV)

The ADIS-IV is a semi-structured diagnostic interview for anxiety disorders (based on DSM-IV criteria). DSM-IV criteria for panic disorder include recurrent unexpected panic attacks and (1) persistant concern or worry about additional panic attacks or their consequences or (2) significant change in behavior related to panic attacks.

Time frame: 3 Months

ArmMeasureGroupValue (NUMBER)
MCET-VAnxiety Disorders Interview Schedule- DSM-IV (ADIS-IV)Participants without panic disorder100 percentage of participants
MCET-VAnxiety Disorders Interview Schedule- DSM-IV (ADIS-IV)Participants with panic disorder0 percentage of participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026